Clinical Characteristics and Treatment of Juvenile Myasthenia Gravis—A Single-Center Experience
Children · 09.05.2024 · 11 (5) · 572
DOI: 10.3390/children11050572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Children, online erschienen am 09.05.2024. Verfasst von Mikiko Maeda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hyogo Medical University School of Medicine, 1-1, Mukogawa, Nishinomiya 663-8501, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Juvenile myasthenia gravis (MG) is a rare autoimmune neuromuscular disease, often treated with anticholinesterases, corticosteroids, and immunosuppressants. However, optimal treatment durations remain unclear. This study investigated the clinical characteristics and treatment of juvenile MG, including medication duration. The administration period for all drugs, immunosuppressants, and prednisolone at doses greater than 0.35 mg/kg daily was extracted retrospectively from medical records. Nineteen participants (8 boys, 11 girls) aged 8 months to 14 years (median, 2.5 years) at onset were identified. Fourteen patients (73.7%) had ocular MG and five (26.3%) had generalized MG. Drug treatment was conducted in 18 cases; however, 7 patients did not complete the treatment. Among the patients who completed drug treatment, the duration of treatment ranged from 11 to 100 months (median, 47 months). In the six patients treated with continuous administration of prednisolone or immunosuppressants, the treatment duration ranged from 33 to 99 months (median, 56 months). No severe adverse effects requiring hospitalization were reported. The patients treated with prednisolone or immunosuppressants required at least 33 months of treatment. These results will help develop protocols for juvenile MG treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Hyogo Medical University School of Medicine, 1-1, Mukogawa, Nishinomiya 663-8501, Japan.
ORCID-Profile: Hideki Shimomura, Yasuhiro Takeshima
Zitieren
APA
Maeda, M., Shimomura, H., Tokunaga, S., Taniguchi, N., Lee, T., & Takeshima, Y. (2024). Clinical Characteristics and Treatment of Juvenile Myasthenia Gravis—A Single-Center Experience. Children, 11(5), 572. https://doi.org/10.3390/children11050572
Vancouver
Maeda M, Shimomura H, Tokunaga S, Taniguchi N, Lee T, Takeshima Y. Clinical Characteristics and Treatment of Juvenile Myasthenia Gravis—A Single-Center Experience. Children. 2024;11(5):572. doi:10.3390/children11050572
BibTeX
@article{Maeda2024,
author = {Maeda, Mikiko and Shimomura, Hideki and Tokunaga, Sachi and Taniguchi, Naoko and Lee, Tomoko and Takeshima, Yasuhiro},
title = {Clinical Characteristics and Treatment of Juvenile Myasthenia Gravis—A Single-Center Experience},
journal = {Children},
year = {2024},
volume = {11},
number = {5},
pages = {572},
doi = {10.3390/children11050572}
}
EUVIMED